PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients...
PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
About this item
Full title
PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Publisher
New York: PR Newswire Association LLC
Journal title
PR Newswire, 2021
Language
English
Formats
Publication information
Publisher
New York: PR Newswire Association LLC
Subjects
More information
Alternative Titles
Full title
PTC Therapeutics to Host Call to Review Results from its Study of Translarna™ (ataluren) in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2486197992
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2486197992
How to access this item
Log in as a Library member
